288 related articles for article (PubMed ID: 24626171)
1. Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines.
Kim SH; Jang YS
Exp Mol Med; 2014 Mar; 46(3):e85. PubMed ID: 24626171
[TBL] [Abstract][Full Text] [Related]
2. M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis.
Corr SC; Gahan CC; Hill C
FEMS Immunol Med Microbiol; 2008 Jan; 52(1):2-12. PubMed ID: 18081850
[TBL] [Abstract][Full Text] [Related]
3. Targeting of mucosal vaccines to Peyer's patch M cells.
Frey A; Neutra MR
Behring Inst Mitt; 1997 Feb; (98):376-89. PubMed ID: 9382762
[TBL] [Abstract][Full Text] [Related]
4. Effect of Avridine on enteric antigen uptake and mucosal immunity to reovirus (1/Lang).
Anderson AO; Rubin DH
Adv Exp Med Biol; 1985; 186():579-90. PubMed ID: 4050592
[No Abstract] [Full Text] [Related]
5. Manipulating systemic and mucosal immune responses with skin-deliverable adjuvants.
Chin J; San Gil F; Novak M; Eamens G; Djordjevic S; Simecka J; Duncan J; Mullbacher A
J Biotechnol; 1996 Jan; 44(1-3):13-9. PubMed ID: 8717381
[TBL] [Abstract][Full Text] [Related]
6. Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.
Brayden DJ; Jepson MA; Baird AW
Drug Discov Today; 2005 Sep; 10(17):1145-57. PubMed ID: 16182207
[TBL] [Abstract][Full Text] [Related]
7. Application of an M-cell-targeting ligand for oral vaccination induces efficient systemic and mucosal immune responses against a viral antigen.
Kim SH; Jung DI; Yang IY; Jang SH; Kim J; Truong TT; Pham TV; Truong NU; Lee KY; Jang YS
Int Immunol; 2013 Nov; 25(11):623-32. PubMed ID: 23900425
[TBL] [Abstract][Full Text] [Related]
8. M cell-targeting strategy enhances systemic and mucosal immune responses induced by oral administration of nuclease-producing L. lactis.
Takahashi K; Yano A; Watanabe S; Langella P; Bermúdez-Humarán LG; Inoue N
Appl Microbiol Biotechnol; 2018 Dec; 102(24):10703-10711. PubMed ID: 30310964
[TBL] [Abstract][Full Text] [Related]
9. The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag.
Peters C; Peng X; Douven D; Pan ZK; Paterson Y
J Immunol; 2003 May; 170(10):5176-87. PubMed ID: 12734365
[TBL] [Abstract][Full Text] [Related]
10. M cells: portals to the mucosal immune system.
Featherstone C
Lancet; 1997 Oct; 350(9086):1230. PubMed ID: 9652575
[No Abstract] [Full Text] [Related]
11. The mucosal immune system.
MacDonald TT
Parasite Immunol; 2003 May; 25(5):235-46. PubMed ID: 12969442
[TBL] [Abstract][Full Text] [Related]
12. Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response.
Hase K; Kawano K; Nochi T; Pontes GS; Fukuda S; Ebisawa M; Kadokura K; Tobe T; Fujimura Y; Kawano S; Yabashi A; Waguri S; Nakato G; Kimura S; Murakami T; Iimura M; Hamura K; Fukuoka S; Lowe AW; Itoh K; Kiyono H; Ohno H
Nature; 2009 Nov; 462(7270):226-30. PubMed ID: 19907495
[TBL] [Abstract][Full Text] [Related]
13. Towards targeting strategies for oral immunization--identification of marker antigens in rat M cells.
Rautenberg K; Cichon C; Schmidt MA
Behring Inst Mitt; 1997 Feb; (98):361-75. PubMed ID: 9382761
[TBL] [Abstract][Full Text] [Related]
14. A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.
Shima H; Watanabe T; Fukuda S; Fukuoka S; Ohara O; Ohno H
Int Immunol; 2014 Nov; 26(11):619-25. PubMed ID: 24908678
[TBL] [Abstract][Full Text] [Related]
15. Systemic and mucosal immunity induced by attenuated Salmonella enterica serovar Typhimurium expressing ORF7 of porcine reproductive and respiratory syndrome virus.
Han YW; Kim SB; Rahman M; Uyangaa E; Lee BM; Kim JH; Park KI; Hong JT; Han SB; Eo SK
Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):335-45. PubMed ID: 21543119
[TBL] [Abstract][Full Text] [Related]
16. [Mucosal immunology].
Nochi T; Kiyono H
Nihon Rinsho; 2005 Apr; 63 Suppl 4():14-9. PubMed ID: 15861629
[No Abstract] [Full Text] [Related]
17. Soluble RANKL expression in Lactococcus lactis and investigation of its potential as an oral vaccine adjuvant.
Kim JI; Park TE; Maharjan S; Li HS; Lee HB; Kim IS; Piao D; Lee JY; Cho CS; Bok JD; Hong ZS; Kang SK; Choi YJ
BMC Immunol; 2015 Nov; 16():71. PubMed ID: 26608025
[TBL] [Abstract][Full Text] [Related]
18. Modulating dendritic cells to optimize mucosal immunization protocols.
Williamson E; Westrich GM; Viney JL
J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
[TBL] [Abstract][Full Text] [Related]
19. Oral immunization with poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres containing pneumotropic bacterial antigens.
Kofler N; Ruedl C; Rieser C; Wick G; Wolf H
Int Arch Allergy Immunol; 1997 Aug; 113(4):424-31. PubMed ID: 9250588
[TBL] [Abstract][Full Text] [Related]
20. Expression and characterization of an M cell-specific ligand-fused dengue virus tetravalent epitope using Saccharomyces cerevisiae.
Nguyen NL; So KK; Kim JM; Kim SH; Jang YS; Yang MS; Kim DH
J Biosci Bioeng; 2015 Jan; 119(1):19-27. PubMed ID: 25027708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
